FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079737694> ?p ?o ?g. }

• W2079737694 endingPage "663" @default.
• W2079737694 startingPage "647" @default.
• W2079737694 abstract "Introduction: Inhibitors of sodium-glucose cotransporters type 2 (SGLT2), which increase urinary glucose excretion independently of insulin, are proposed as a novel approach for the management of type 2 diabetes mellitus (T2DM). Areas covered: An extensive literature search was performed to analyze the pharmacokinetic characteristics, toxicological issues and safety concerns of SGLT2 inhibitors in humans. This review focuses on three compounds (dapagliflozin, canagliflozin, empagliflozin) with results obtained in healthy volunteers (including drug–drug interactions), patients with T2DM (single dose and multiple doses) and special populations (those with renal or hepatic impairment). Expert opinion: The three pharmacological agents share an excellent oral bioavailability, long half-life allowing once-daily administration, low accumulation index and renal clearance, the absence of active metabolites and a limited propensity to drug–drug interactions. No clinically relevant changes in pharmacokinetic parameters were observed in T2DM patients or in patients with mild/moderate renal or hepatic impairment. Adverse events are a slightly increased incidence of mycotic genital and rare benign urinary infections. SGLT2 inhibitors have the potential to reduce several cardiovascular risk factors, and cardiovascular outcome trials are currently ongoing. The best positioning of SGLT2 inhibitors in the armamentarium for treating T2DM is still a matter of debate." @default.
• W2079737694 created "2016-06-24" @default.
• W2079737694 creator A5039563874 @default.
• W2079737694 date "2014-01-03" @default.
• W2079737694 modified "2023-09-24" @default.
• W2079737694 title "Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations" @default.
• W2079737694 cites W104021497 @default.
• W2079737694 cites W1606165384 @default.
• W2079737694 cites W1606827863 @default.
• W2079737694 cites W175419662 @default.
• W2079737694 cites W1945535054 @default.
• W2079737694 cites W1963647800 @default.
• W2079737694 cites W1968328731 @default.
• W2079737694 cites W1975416254 @default.
• W2079737694 cites W1983085727 @default.
• W2079737694 cites W1985015752 @default.
• W2079737694 cites W1988704430 @default.
• W2079737694 cites W1995615699 @default.
• W2079737694 cites W1997018189 @default.
• W2079737694 cites W2007832417 @default.
• W2079737694 cites W2015696027 @default.
• W2079737694 cites W2019932241 @default.
• W2079737694 cites W2020151823 @default.
• W2079737694 cites W2025613244 @default.
• W2079737694 cites W2029355071 @default.
• W2079737694 cites W2036383296 @default.
• W2079737694 cites W2036504033 @default.
• W2079737694 cites W2038961968 @default.
• W2079737694 cites W2043440255 @default.
• W2079737694 cites W2050658162 @default.
• W2079737694 cites W2052976889 @default.
• W2079737694 cites W2057601938 @default.
• W2079737694 cites W2060530397 @default.
• W2079737694 cites W2064952777 @default.
• W2079737694 cites W2068225029 @default.
• W2079737694 cites W2069488406 @default.
• W2079737694 cites W2069662979 @default.
• W2079737694 cites W2069845056 @default.
• W2079737694 cites W2070351793 @default.
• W2079737694 cites W2071903650 @default.
• W2079737694 cites W2072040765 @default.
• W2079737694 cites W2075224373 @default.
• W2079737694 cites W2077038286 @default.
• W2079737694 cites W2078992128 @default.
• W2079737694 cites W2080383778 @default.
• W2079737694 cites W2083214694 @default.
• W2079737694 cites W2084511068 @default.
• W2079737694 cites W2088150452 @default.
• W2079737694 cites W2090563376 @default.
• W2079737694 cites W2097519488 @default.
• W2079737694 cites W2104243240 @default.
• W2079737694 cites W2105660444 @default.
• W2079737694 cites W2111876001 @default.
• W2079737694 cites W2114250030 @default.
• W2079737694 cites W2120600312 @default.
• W2079737694 cites W2121367181 @default.
• W2079737694 cites W2123063175 @default.
• W2079737694 cites W2128219379 @default.
• W2079737694 cites W2149973065 @default.
• W2079737694 cites W2153839551 @default.
• W2079737694 cites W2155997251 @default.
• W2079737694 cites W2159883745 @default.
• W2079737694 cites W2162427196 @default.
• W2079737694 cites W2165783452 @default.
• W2079737694 cites W2169403426 @default.
• W2079737694 cites W2171049608 @default.
• W2079737694 doi "https://doi.org/10.1517/17425255.2014.873788" @default.
• W2079737694 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24387329" @default.
• W2079737694 hasPublicationYear "2014" @default.
• W2079737694 type Work @default.
• W2079737694 sameAs 2079737694 @default.
• W2079737694 citedByCount "53" @default.
• W2079737694 countsByYear W20797376942014 @default.
• W2079737694 countsByYear W20797376942015 @default.
• W2079737694 countsByYear W20797376942016 @default.
• W2079737694 countsByYear W20797376942017 @default.
• W2079737694 countsByYear W20797376942018 @default.
• W2079737694 countsByYear W20797376942019 @default.
• W2079737694 countsByYear W20797376942020 @default.
• W2079737694 countsByYear W20797376942021 @default.
• W2079737694 countsByYear W20797376942022 @default.
• W2079737694 countsByYear W20797376942023 @default.
• W2079737694 crossrefType "journal-article" @default.
• W2079737694 hasAuthorship W2079737694A5039563874 @default.
• W2079737694 hasConcept C112705442 @default.
• W2079737694 hasConcept C134018914 @default.
• W2079737694 hasConcept C177713679 @default.
• W2079737694 hasConcept C197934379 @default.
• W2079737694 hasConcept C2775887513 @default.
• W2079737694 hasConcept C2777180221 @default.
• W2079737694 hasConcept C2777422806 @default.
• W2079737694 hasConcept C2777451236 @default.
• W2079737694 hasConcept C2780035454 @default.
• W2079737694 hasConcept C2910068830 @default.
• W2079737694 hasConcept C555293320 @default.
• W2079737694 hasConcept C71924100 @default.
• W2079737694 hasConcept C90466245 @default.
• W2079737694 hasConcept C98274493 @default.

• next